IFI30 and Familial prostate cancer: Similar to the observation of the present study, previous research has discovered that GILT was absent or expressed at greatly reduced levels in several malignant diseases, such as melanomas [12], [21], prostate cancer [22] and glioblastoma [23], indicating a potential role of GILT in tumorigenesis.